Status:
COMPLETED
The Effect of CoQ10 Administration on Hemodialysis Patients
Lead Sponsor:
University of Shizuoka
Conditions:
Chronic Renal Failure
Hemodialysis
Eligibility:
All Genders
Up to 85 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to examine whether CoQ10 administration is effective as an antioxidant in hemodialysis patients.
Detailed Description
Oxidative stress has been recognized as a potential risk factor for such complications as atherosclerosis in hemodialysis patients. This study investigates whether CoQ10 administration is effective fo...
Eligibility Criteria
Inclusion
- hemodialysis for at least 6 months
Exclusion
- none
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00307996
Start Date
March 1 2004
End Date
December 1 2004
Last Update
March 28 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iwata City Hospital
Iwata, Shizuoka, Japan, 438-8550